Nadide

The dosage of Nadide is highly individualized and must be determined by a qualified healthcare professional based on the patient's clinical needs and the route of administration.

• For General Metabolic Support (Oral): The typical adult dosage ranges from 50 mg to 250 mg daily. Some practitioners may suggest higher doses up to 500 mg for specific metabolic conditions, though clinical data on long-term high-dose oral supplementation is still evolving.
• For Chronic Fatigue or Fibromyalgia (Oral/Sublingual): Dosages often start at 10 mg to 20 mg daily, taken on an empty stomach to maximize absorption. If tolerated, the dose may be titrated up to 50 mg daily.
• For Substance Use Recovery (IV): This protocol is intensive and must be performed under medical supervision. Standard protocols involve 500 mg to 1,500 mg of Nadide infused intravenously over 4 to 8 hours daily for a period of 10 to 14 consecutive days.
• For Age-Related Wellness (IM): Intramuscular injections are often administered at 100 mg to 200 mg once or twice weekly.

Nadide is not currently FDA-approved for general use in pediatric populations. Its use in children is restricted to the treatment of specific, rare metabolic or genetic disorders under the strict guidance of a pediatric metabolic specialist. Standard pediatric dosing has not been established for general wellness or fatigue. Do not administer Nadide to a child unless specifically directed by a physician.

Renal Impairment

Patients with significant kidney disease (Stage 3 or higher) should use Nadide with caution. While Nadide metabolites are excreted renally, there is limited data on whether accumulation occurs in patients with reduced glomerular filtration rates (GFR). Healthcare providers may consider a 25-50% dose reduction in patients with severe renal impairment.

Hepatic Impairment

The liver is the primary site of Nadide synthesis and processing via the salvage pathway. In patients with cirrhosis or advanced hepatic dysfunction, the ability to process nicotinamide may be impaired. Monitoring of liver enzymes is recommended during high-dose therapy.

Elderly Patients

Geriatric patients often have lower baseline NAD+ levels and may benefit from supplementation. However, due to the higher prevalence of cardiovascular and renal comorbidities in this population, clinicians typically start at the lowest effective dose and monitor for side effects like increased heart rate or blood pressure during IV administration.

To ensure the best results and minimize side effects, follow these administration guidelines:

• Oral Forms: Take Nadide tablets or capsules on an empty stomach, ideally 30 minutes before breakfast. This prevents competition with dietary proteins and fats for absorption. Swallow the tablets whole; do not crush or chew enteric-coated versions, as this may lead to premature degradation by stomach acid.
• Sublingual Forms: Place the tablet under the tongue and allow it to dissolve completely. Avoid eating or drinking for 15 minutes after the tablet has dissolved.
• IV Infusion: Ensure you are well-hydrated before the appointment. During the infusion, it is common to feel a 'chest pressure' or 'abdominal heaviness' if the drip rate is too fast. Inform the medical staff immediately if these sensations become uncomfortable, as they can be managed by slowing the infusion rate.
• Storage: Store oral Nadide in a cool, dry place away from direct sunlight. Some liquid or injectable forms may require refrigeration (36°F to 46°F or 2°C to 8°C); check the product label for specific storage requirements.

If you miss a dose of oral Nadide, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. For missed IV or IM appointments, contact your clinic to reschedule as soon as possible to maintain therapeutic levels.

Acute toxicity from Nadide is rare because it is a water-soluble coenzyme that the body can generally excrete. However, excessive doses (particularly IV) can lead to:

• Severe nausea and vomiting
• Intense skin flushing and itching
• Rapid heartbeat (tachycardia)
• Shortness of breath
• Excessive sweating

In the event of a suspected overdose, seek emergency medical attention or contact a poison control center immediately. Treatment is generally supportive, focusing on hydration and monitoring of cardiovascular vitals.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or administration method without medical guidance, as this can affect both the safety and efficacy of the treatment.

Most patients tolerate Nadide well, particularly in oral forms. However, during intravenous administration, side effects are common due to the rapid increase in systemic NAD+ levels. Common experiences include:

• Gastrointestinal Distress: Nausea, abdominal cramping, or a 'heavy' feeling in the stomach. This is most frequent during IV infusions and usually subsides within minutes of slowing the drip rate.
• Chest Pressure: A sensation of tightness or pressure in the chest area. While this can be alarming, in the context of Nadide IV, it is typically a physiological response to the coenzyme and not a cardiac event. However, it must always be reported to the attending clinician.
• Flushing: A warm, red, or itchy sensation on the skin, similar to a 'niacin flush.' This occurs because Nadide is a derivative of Vitamin B3, which can cause vasodilation (widening of blood vessels).
• Headache: Some patients report a mild to moderate tension-type headache following administration.

• Fatigue: While Nadide is often used to treat fatigue, some patients experience a paradoxical 'crash' or tiredness immediately following a high-dose treatment as the body adjusts to the metabolic shift.
• Dizziness or Lightheadedness: This may occur especially if the patient stands up too quickly after an infusion.
• Muscle Soreness: Some patients report mild aching in the muscles, particularly in the upper back and shoulders.
• Anxiety or Jitteriness: Because Nadide supports cellular energy, it can occasionally cause a feeling of over-stimulation or restlessness.

• Insomnia: If taken late in the day, Nadide’s energy-boosting effects may interfere with sleep patterns.
• Liver Enzyme Elevation: In very rare cases of extremely high-dose, long-term use, transient elevations in liver enzymes have been noted, requiring cessation of the supplement.
• Hypersensitivity Reactions: Rare allergic responses including rash or hives.

> Warning: Stop taking Nadide and call your doctor immediately or seek emergency care if you experience any of the following:

• Anaphylaxis: Signs include swelling of the face, lips, or tongue; difficulty breathing; severe wheezing; or a rapid, weak pulse.
• Severe Cardiac Symptoms: While mild chest pressure is common during IV use, any intense chest pain, pain radiating to the jaw or left arm, or severe heart palpitations should be evaluated immediately to rule out a myocardial infarction (heart attack).
• Severe Hypotension: A sudden, dramatic drop in blood pressure leading to fainting (syncope).
• Psychological Distress: Sudden onset of intense panic attacks or severe agitation.

Because Nadide (NAD+) is a relatively new focus in clinical longevity medicine, long-term data over decades is still being gathered. Potential considerations for long-term use include:

• Methylation Depletion: High doses of Nadide require methyl groups for metabolism and excretion. Prolonged use without adequate B12 and folate support could theoretically lead to a depletion of the body's 'methyl pool,' potentially affecting mood and homocysteine levels.
• Metabolic Adaptation: There is a theoretical concern that the body might downregulate its own endogenous production of NAD+ if high-dose exogenous sources are provided indefinitely. For this reason, many clinicians recommend 'pulsed' dosing (e.g., 5 days on, 2 days off).

As of 2026, there are no FDA black box warnings for Nadide. It is generally recognized as safe when used under medical supervision. However, because it is often sold as a dietary supplement, the quality and purity of the product can vary significantly. Always ensure you are using a pharmaceutical-grade product verified by third-party testing.

Report any unusual or persistent symptoms to your healthcare provider. Keeping a 'symptom diary' can help your doctor determine if side effects are dose-related or if a different form of Nadide would be better tolerated.

Nadide is a potent metabolic modulator. While it is a naturally occurring coenzyme, introducing concentrated amounts into the system can significantly alter cellular signaling. It should never be used as a substitute for conventional medical treatment for serious diseases but rather as a supportive adjunct under professional guidance.

No FDA black box warnings for Nadide have been issued as of the current 2026 clinical guidelines.

• Allergic Reactions / Anaphylaxis Risk: Patients with a known hypersensitivity to Vitamin B3 (niacin) or any component of the Nadide formulation should avoid use. Initial doses should be low to assess tolerance.
• Cardiovascular Health: Because Nadide can cause transient changes in blood pressure and heart rate (especially during IV administration), patients with pre-existing arrhythmias, unstable angina, or severe hypertension must be monitored closely.
• Active Malignancy (Cancer): There is a complex relationship between NAD+ and cancer. While NAD+ supports DNA repair (which prevents cancer), some studies suggest that established tumors may 'hijack' NAD+ pathways to support their own rapid metabolic needs and DNA repair. Patients with active cancer or a history of recent malignancy should consult an oncologist before using Nadide.
• Diabetes and Blood Glucose: Nadide plays a role in insulin sensitivity and glucose metabolism. Patients with Type 1 or Type 2 diabetes should monitor their blood sugar levels closely when starting Nadide, as medication requirements for insulin or oral hypoglycemics may change.

If you are on long-term or high-dose Nadide therapy, your healthcare provider may require the following tests:

• Liver Function Tests (LFTs): To ensure that the hepatic salvage pathway is processing the coenzyme without stress.
• Homocysteine Levels: To monitor for potential methylation depletion.
• Renal Function (BUN/Creatinine): To ensure the kidneys are effectively clearing metabolites.
• Blood Glucose / HbA1c: For patients with metabolic syndrome or diabetes.

Nadide generally does not cause sedation. However, because some patients experience dizziness or a 'metabolic rush' immediately after an IV infusion or a high oral dose, you should determine how you react to the medication before driving or operating heavy machinery. It is advisable to wait at least 30 minutes after an IV treatment before driving.

Alcohol consumption depletes the body's NAD+ stores as the liver uses NAD+ to metabolize ethanol into acetaldehyde. While Nadide is used to treat alcohol withdrawal, consuming alcohol while taking Nadide supplements is counterproductive and may increase the risk of liver strain. It is strongly recommended to avoid or significantly limit alcohol during treatment.

There is no evidence of a physical withdrawal syndrome associated with stopping Nadide. However, patients using it for chronic fatigue or mood support may notice a gradual return of their original symptoms as cellular NAD+ levels return to their baseline. It is generally best to taper the dose over a week rather than stopping abruptly to allow the body's endogenous production pathways to recalibrate.

> Important: Discuss all your medical conditions, including any history of gout, liver disease, or peptic ulcers, with your healthcare provider before starting Nadide, as Vitamin B3 derivatives can occasionally exacerbate these conditions.

While Nadide is generally safe, certain combinations are contraindicated due to the risk of severe adverse reactions:

• Certain Chemotherapy Agents: Because Nadide enhances DNA repair mechanisms via PARP activation, it may theoretically reduce the efficacy of chemotherapy drugs that work by causing DNA damage to cancer cells (e.g., alkylating agents like cyclophosphamide or platinum-based drugs like cisplatin). Always consult an oncologist.
• High-Dose Statins: There is a theoretical risk of increased muscle toxicity (myopathy) when combining high-dose Vitamin B3 derivatives with certain statins, though this is more commonly associated with nicotinic acid than pure Nadide.

• Antidiabetic Medications: Nadide can influence insulin sensitivity. When taken with drugs like metformin, glipizide, or insulin, it may increase the glucose-lowering effect, potentially leading to hypoglycemia (low blood sugar). Dosage adjustments of the diabetes medication may be necessary.
• Antihypertensive Drugs: Nadide can cause vasodilation. If taken with blood pressure medications (like ACE inhibitors or beta-blockers), it may cause an additive effect, leading to excessively low blood pressure.

• Blood Thinners (Anticoagulants/Antiplatelets): The provided EPC tags suggest Nadide may have anti-coagulant properties. Taking it with warfarin, aspirin, or clopidogrel may slightly increase the risk of bruising or bleeding. Monitor for any unusual signs of bleeding.
• Adrenergic Agonists: As Nadide is linked to alpha and beta-adrenergic pathways, it may interact with asthma inhalers or decongestants, potentially increasing heart rate or blood pressure.

• High-Protein Meals: Tryptophan in protein-rich foods is a natural precursor to NAD+. While not a negative interaction, a very high-protein diet may lessen the perceived 'boost' from supplementation.
• Caffeine: Combining Nadide with high doses of caffeine can exacerbate feelings of jitteriness, anxiety, or rapid heart rate.

• Resveratrol / Pterostilbene: These polyphenols activate sirtuins, the enzymes that consume Nadide. Taking them together is often recommended by 'longevity' experts to synergize effects, but it may also increase the 'demand' for Nadide, requiring higher doses.
• Niacin (Vitamin B3): Taking Nadide with other forms of B3 (nicotinic acid or nicotinamide) increases the risk of flushing and potential liver strain.
• Methyl Donors (TMG, B12, Folate): It is often recommended to take Trimethylglycine (TMG) or methylated B-vitamins with Nadide to prevent the depletion of methyl groups.

Nadide may interfere with certain laboratory tests that rely on NAD+/NADH redox reactions for measurement (common in some enzymatic assays for LDH or ALT). Inform your lab technician if you have received an IV Nadide treatment within 24 hours of a blood draw.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. This includes over-the-counter vitamins and 'pre-workout' supplements which may contain hidden niacin or stimulants.

Nadide must NEVER be used in the following circumstances:

1. 1Known Hypersensitivity: If you have had a previous severe allergic reaction (anaphylaxis, severe rash, or angioedema) to Nadide, Nicotinamide, or Niacin.
2. 2Active Peptic Ulcer Disease: High doses of B3 derivatives can stimulate gastric acid secretion and worsen existing ulcers, potentially leading to gastrointestinal bleeding.
3. 3Severe Hepatic Failure: In patients with decompensated cirrhosis or acute liver failure, the liver cannot process the coenzyme, which may lead to metabolic imbalances.

Conditions requiring a careful risk-benefit analysis by a physician:

• History of Gout: Nadide metabolites can compete with uric acid for excretion in the kidneys, potentially raising serum uric acid levels and triggering a gout flare.
• Cardiac Arrhythmias: Those with a history of atrial fibrillation or supraventricular tachycardia should be monitored, as the metabolic 'surge' from Nadide can occasionally trigger an episode.
• Pregnancy and Lactation: Due to a lack of robust clinical trial data in these populations, use is generally discouraged unless the benefits clearly outweigh the unknown risks.
• Schizophrenia or Bipolar Disorder: Some older studies suggested that very high doses of B3 derivatives could affect neurotransmitter methylation, potentially exacerbating symptoms in sensitive individuals.

Patients who are sensitive to Nicotinic Acid (Niacin) or Nicotinamide are highly likely to be sensitive to Nadide. While Nadide is often reported to cause less 'flush' than pure nicotinic acid, the risk remains significant for those with a known allergy to the B3 vitamin family.

> Important: Your healthcare provider will evaluate your complete medical history, including any history of kidney stones or gallbladder disease, before prescribing Nadide.

FDA Pregnancy Category: Not formally assigned (often considered Category C).

There are no adequate and well-controlled studies of Nadide in pregnant women. While NAD+ is a natural molecule essential for fetal development, the safety of high-dose exogenous supplementation is unknown. Animal studies on NAD+ precursors have shown both benefits for preventing birth defects and potential risks at extremely high doses. Nadide should be used during pregnancy only if clearly needed and prescribed by a physician who can weigh the developmental benefits against the lack of safety data.

It is not known whether exogenous Nadide passes into human breast milk in significant quantities. While nicotinamide is a normal component of breast milk, the impact of high-dose Nadide on a nursing infant’s developing metabolism has not been studied. Nursing mothers should consult their pediatrician before starting Nadide supplements.

Safety and effectiveness in pediatric patients have not been established. Use in children is typically limited to specialized medical cases involving inborn errors of metabolism. Because NAD+ is involved in growth signaling pathways, unauthorized use in children could theoretically interfere with normal developmental processes.

Clinical interest in Nadide is highest in the geriatric population (ages 65+). Research indicates that systemic NAD+ levels decline by up to 50% between age 20 and age 60. Geriatric patients may experience improved cognitive clarity and physical energy with Nadide. However, this population is also more susceptible to side effects like transient hypertension or increased heart rate. Clinicians often recommend a 'start low, go slow' approach for seniors, with frequent monitoring of renal function.

For patients with a GFR below 60 mL/min/1.73m², the clearance of Nadide metabolites (like N-methylnicotinamide) may be reduced. While not directly nephrotoxic, the accumulation of these metabolites could potentially cause nausea or itching. Dose adjustments are recommended for patients with Stage 3-5 Chronic Kidney Disease.

In patients with mild to moderate hepatic impairment (Child-Pugh Class A or B), Nadide should be used with caution. The liver's salvage pathway is the primary site of NAD+ regulation. In severe hepatic impairment (Class C), the use of high-dose Nadide is generally contraindicated due to the risk of metabolic derangement.

> Important: Special populations require individualized medical assessment. Never start a supplement regimen for a child, elderly relative, or during pregnancy without professional medical oversight.

Nadide (NAD+) acts as a coenzyme for oxidoreductases, enzymes that catalyze electron transfer. In its oxidized form (NAD+), it acts as an oxidizing agent, accepting electrons from other molecules and becoming reduced to NADH. This NADH then acts as a reducing agent to donate electrons.

Specifically, Nadide targets:

• The Mitochondrial Respiratory Chain: Acting as the primary electron donor for Complex I (NADH:ubiquinone oxidoreductase).
• Sirtuins (SIRT1-7): Functioning as a substrate for these NAD+-dependent deacetylases which regulate metabolic homeostasis and DNA repair.
• PARPs (Poly-ADP Ribose Polymerases): Serving as a substrate for DNA damage sensors.
• CD38/Cyclic ADP-ribose hydrolases: Regulating intracellular calcium signaling.

• Onset of Action: Following IV administration, metabolic changes (such as increased cellular respiration) occur within minutes. For oral use, clinical effects on energy and cognition may take 2-4 weeks of consistent dosing to become apparent.
• Duration of Effect: The acute 'boost' from an IV infusion may last 24-48 hours, but the cumulative effects on cellular repair and protein expression can persist for weeks.
• Tolerance: There is no evidence of pharmacological tolerance; however, the body’s 'set point' for NAD+ may adjust, requiring consistent intake to maintain elevated levels.

| Parameter | Value |

|---|---|

| Bioavailability | <10% (Oral), 100% (IV) |

| Protein Binding | Low (primarily free in plasma) |

| Half-life | 1-2 hours (Plasma) |

| Tmax | 0.5 - 2 hours (Oral/Sublingual) |

| Metabolism | Hepatic (Salvage Pathway / Methylation) |

| Excretion | Renal (>90% as metabolites) |

• Molecular Formula: C21H27N7O14P2
• Molecular Weight: 663.43 g/mol
• Solubility: Highly soluble in water; insoluble in organic solvents.
• Structure: A dinucleotide consisting of an adenine ring and a nicotinamide ring linked by a pair of bridging phosphate groups.

Nadide is a Coenzyme / Vitamin B3 Derivative. It is closely related to Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN), which are precursors that the body converts into Nadide.